These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 12271729)

  • 1. [The comparative study of the safety of a vaccinal process in both oral and epicutaneous immunization against smallpox].
    Bektimirov TA; Podkuĭko VN; Grigor'eva LV; Perekrest VV; Mikhaĭlov VV; Tereshkina NV; Dorokhina TV
    Vopr Virusol; 2002; 47(4):9-13. PubMed ID: 12271729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of the vaccinal process in skin-scarification and oral immunization of rabbits with live smallpox vaccines].
    Podkuĭko VN; Vorob'ev AA; Maksimov VA
    Zh Mikrobiol Epidemiol Immunobiol; 2005; (5):40-5. PubMed ID: 16279533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Peroral immunization--a method for enhancing the safety of the recombinant vector (the vaccinia virus)].
    Podkuĭko VN; Vorob'ev AA; Krasnianskiĭ VP; Patrikeev GT; Mikhaĭlov VV; Dorokhina TV; Makhlaĭ AA; Dykanov GA
    Vestn Ross Akad Med Nauk; 1993; (2):39-44. PubMed ID: 7688619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Results of basic and applied investigations on oral immunization against smallpox ].
    Vorob'ev AA; Podkuĭko VN; Mikhaĭlov VV
    Zh Mikrobiol Epidemiol Immunobiol; 2002; (1):98-104. PubMed ID: 11949269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral immunization against smallpox.
    Hochstein-Mintzel V; Stickl H; Huber HC
    Dev Biol Stand; 1976; 33():260-6. PubMed ID: 182585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Oral and nasal immunization with Poxvirus vacciniae. I. Criteria for smallpox immunity and immunology of the conventional cutaneous reaction to vaccination].
    Hochstein-Mintzel V
    Zentralbl Bakteriol Orig B; 1972 Aug; 156(1):1-14. PubMed ID: 4575333
    [No Abstract]   [Full Text] [Related]  

  • 7. [MVA vaccination against smallpox: clinical tests with an attenuated live vaccinia virus strain (MVA) (author's transl)].
    Stickl H; Hochstein-Mintzel V; Mayr A; Huber HC; Schäfer H; Holzner A
    Dtsch Med Wochenschr; 1974 Nov; 99(47):2386-92. PubMed ID: 4426258
    [No Abstract]   [Full Text] [Related]  

  • 8. Persistence of vaccinia at the site of smallpox vaccination.
    Cummings JF; Polhemus ME; Hawkes C; Klote M; Ludwig GV; Wortmann G
    Clin Infect Dis; 2008 Jan; 46(1):101-2. PubMed ID: 18171221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Oral vaccination against smallpox (on the return of smallpox vaccination)].
    Vorob'ev AA; Podkuĭko VN; Maksimov VA
    Vestn Ross Akad Med Nauk; 2003; (1):5-10. PubMed ID: 12608077
    [No Abstract]   [Full Text] [Related]  

  • 10. Absence of pharyngeal shedding of vaccinia following smallpox vaccination.
    Talbot TR; Peters J; Wright PF; Edwards KM
    Am J Infect Control; 2007 Sep; 35(7):486-8. PubMed ID: 17765564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Our experiences with the 2-stage method of vaccination against smallpox (MVA virus pre-vaccination)].
    Rudkowski Z; Remion J; Saraczyńska E
    Pediatr Pol; 1976 May; 51(5):497-503. PubMed ID: 1272640
    [No Abstract]   [Full Text] [Related]  

  • 12. Protective properties of vaccinia virus-based vaccines: skin scarification promotes a nonspecific immune response that protects against orthopoxvirus disease.
    Rice AD; Adams MM; Lindsey SF; Swetnam DM; Manning BR; Smith AJ; Burrage AM; Wallace G; MacNeill AL; Moyer RW
    J Virol; 2014 Jul; 88(14):7753-63. PubMed ID: 24760885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Freeze-dried live attenuated smallpox vaccine prepared in cell culture "LC16-KAKETSUKEN": Post-marketing surveillance study on safety and efficacy compliant with Good Clinical Practice.
    Nishiyama Y; Fujii T; Kanatani Y; Shinmura Y; Yokote H; Hashizume S
    Vaccine; 2015 Nov; 33(45):6120-7. PubMed ID: 26455406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modified Vaccinia Ankara Virus Vaccination Provides Long-Term Protection against Nasal Rabbitpox Virus Challenge.
    Jones DI; McGee CE; Sample CJ; Sempowski GD; Pickup DJ; Staats HF
    Clin Vaccine Immunol; 2016 Jul; 23(7):648-51. PubMed ID: 27146001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative efficacy of modified vaccinia Ankara (MVA) as a potential replacement smallpox vaccine.
    Phelps AL; Gates AJ; Hillier M; Eastaugh L; Ulaeto DO
    Vaccine; 2007 Jan; 25(1):34-42. PubMed ID: 16950548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid spreading and immune evasion by vaccinia virus.
    Smith GL
    Adv Exp Med Biol; 2014; 808():65-76. PubMed ID: 24595611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced immunogenicity and protective effect conferred by vaccination with combinations of modified vaccinia virus Ankara and licensed smallpox vaccine Dryvax in a mouse model.
    Meseda CA; Garcia AD; Kumar A; Mayer AE; Manischewitz J; King LR; Golding H; Merchlinsky M; Weir JP
    Virology; 2005 Sep; 339(2):164-75. PubMed ID: 15993917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The topicality of return to smallpox vaccination: problems and prospects].
    Onishchenko GG; Maksimov VA; Vorob'ev AA; Podkuĭko VN; Mel'nikov SA
    Vestn Ross Akad Med Nauk; 2006; (7):32-8. PubMed ID: 16924876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and immunogenicity of IMVAMUNE, a promising candidate as a third generation smallpox vaccine.
    Vollmar J; Arndtz N; Eckl KM; Thomsen T; Petzold B; Mateo L; Schlereth B; Handley A; King L; Hülsemann V; Tzatzaris M; Merkl K; Wulff N; Chaplin P
    Vaccine; 2006 Mar; 24(12):2065-70. PubMed ID: 16337719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smallpox vaccination of eczema patients with attenuated live vaccinia virus.
    Kempe CH
    Yale J Biol Med; 1968 Aug; 41(1):1-12. PubMed ID: 5683825
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.